Streetbeat News

Stock Prices

ROIV

Roivant Sciences is reportedly in talks with Roche over a $7 billion deal for a stomach disease drug. This news has led to an increase in Roivant's share price.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 8:44 am

AEHR

C

JPM

LESL

WFC

JPMorgan Chase & Co., Aehr Test Systems, Citigroup Inc., Leslie's Inc, and Wells Fargo & Company are the stocks to watch heading into Friday. JPMorgan and Citigroup are expected to post their quarterly earnings before the opening bell. Aehr Test Systems reported better-than-expected results for its fourth quarter. Leslie's Inc released preliminary results for its fiscal third quarter and announced a CFO transition. Wells Fargo is expected to report its quarterly earnings before the opening bell.

Portfolio Pulse from Lisa Levin

July 14, 2023 | 8:41 am

BRKA

BYDDF

TSLA

China’s largest EV maker, BYD Co Ltd, backed by Warren Buffett's Berkshire Hathaway, has proposed a $1 billion investment to build electric cars and batteries in India through a joint venture with a local engineering company. This move could challenge Tesla Inc’s dominance in the EV market and expand BYD's global presence. BYD has already invested $200 million in India and plans to manufacture 100,000 EVs annually in India over the next few years.

Portfolio Pulse from Arpit Nayak

July 14, 2023 | 8:36 am

NOK

Nokia has reduced its net sales guidance and narrowed its operating margin outlook for 2023, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 8:34 am

ERIC

Ericsson reported Q2 losses of $(0.02) per share, missing the analyst consensus estimate of $0.04 by 150 percent. This is a 114.29 percent decrease over earnings of $0.14 per share from the same period last year. The company also reported quarterly sales of $6.12 billion, missing the analyst consensus estimate of $6.13 billion by 0.16 percent, a 3.76 percent decrease over sales of $6.36 billion the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 7:02 am

CRBU

Caribou Biosciences has announced the pricing of its upsized $125M public offering.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:49 am

C

DAL

JPM

PEP

WFC

The CNN Money Fear and Greed index remained in the 'Extreme Greed' zone, indicating high investor confidence. U.S. stocks rose for the fourth consecutive session, with Delta Air Lines and PepsiCo reporting better-than-expected Q2 results. Investors are awaiting earnings results from JPMorgan Chase, Citigroup, and Wells Fargo.

Portfolio Pulse from Lisa Levin

July 14, 2023 | 6:42 am

INDA

India's Wholesale Price Index Inflation for June was reported at -4.12%, lower than the estimated -3.60% and the prior -3.48%.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:37 am

META

Elon Musk, owner of Twitter, has shared his unconventional approach to preparing for a potential fight with Meta Platforms Inc CEO Mark Zuckerberg. The feud between the two billionaires has been escalating, with both parties showing signs of preparing for a physical confrontation. The potential fight between Musk and Zuckerberg could impact the public perception of their respective companies, Twitter and Meta Platforms.

Portfolio Pulse from Benzinga Neuro

July 14, 2023 | 6:27 am

OGI

OrganiGram Holdings reported Q3 losses of $(1.79) per share, a 6292.86% decrease YoY. Quarterly sales were $24.40M, missing the analyst consensus estimate of $31.80M by 23.27%, and marking an 18.64% decrease YoY.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:18 am